Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386424279> ?p ?o ?g. }
- W4386424279 endingPage "110953" @default.
- W4386424279 startingPage "110953" @default.
- W4386424279 abstract "Recent preclinical studies have investigated the atypical kappa-opioid receptor (KOR) agonist, nalfurafine, as a co-formulary with mu-opioid receptor (MOR) agonists as a potential deterrent for misuse. However, no study has investigated effects of nalfurafine combined with a MOR agonist using an oral route of administration. The objective of the current study was to measure behavioral effects of orally administered oxycodone and nalfurafine, alone and combined, in rhesus monkeys using a quantitative behavioral observation procedure. Adult male rhesus monkeys (N=5) were orally administered vehicle, oxycodone (0.56-1.8 mg/kg), nalfurafine (0.001-0.0056 mg/kg), or mixtures (1.0 mg/kg oxycodone/0.001-0.0056 mg/kg nalfurafine) in a Jell-O vehicle at multiple timepoints (10-320 min). Species-typical and drug-induced behaviors were recorded by observers blinded to conditions. Oxycodone alone significantly increased scratch and face-rub behaviors without affecting other behaviors. Nalfurafine decreased baseline levels of scratch without affecting other behaviors, and oxycodone-nalfurafine combinations resulted in reduced oxycodone-induced scratching at a dose (0.001 mg/kg) that did not produce sedation-like effects. Oxycodone combined with larger nalfurafine doses (0.0032-0.0056 mg/kg) also reduced oxycodone induced scratch that were accompanied with sedation-like effects (i.e., increased lip droop). Nalfurafine was orally active in rhesus monkeys, and it reduced oxycodone-induced pruritus at a dose that did not produce sedation-like effects that are commonly observed with prototypical KOR agonists. Combinations of low doses of nalfurafine with MOR agonists such as oxycodone may be well-tolerated by humans who are prescribed MOR agonists for the treatment of pain." @default.
- W4386424279 created "2023-09-05" @default.
- W4386424279 creator A5007574521 @default.
- W4386424279 creator A5019064242 @default.
- W4386424279 creator A5034893026 @default.
- W4386424279 creator A5035496277 @default.
- W4386424279 creator A5043494441 @default.
- W4386424279 creator A5043625052 @default.
- W4386424279 creator A5048006376 @default.
- W4386424279 creator A5056930528 @default.
- W4386424279 date "2023-11-01" @default.
- W4386424279 modified "2023-10-17" @default.
- W4386424279 title "QUANTIFICATION OF OBSERVABLE BEHAVIORS FOLLOWING ORAL ADMINISTRATION OF OXYCODONE AND NALFURAFINE IN MALE RHESUS MONKEYS" @default.
- W4386424279 cites W1775629781 @default.
- W4386424279 cites W1960674406 @default.
- W4386424279 cites W1971805652 @default.
- W4386424279 cites W1983547609 @default.
- W4386424279 cites W2032643119 @default.
- W4386424279 cites W2040659853 @default.
- W4386424279 cites W2055412147 @default.
- W4386424279 cites W2061073557 @default.
- W4386424279 cites W2071590226 @default.
- W4386424279 cites W2076323933 @default.
- W4386424279 cites W2116485956 @default.
- W4386424279 cites W2118617956 @default.
- W4386424279 cites W2131961325 @default.
- W4386424279 cites W2171367696 @default.
- W4386424279 cites W2234927368 @default.
- W4386424279 cites W2557809815 @default.
- W4386424279 cites W2618612984 @default.
- W4386424279 cites W2754536701 @default.
- W4386424279 cites W2765427553 @default.
- W4386424279 cites W2802776460 @default.
- W4386424279 cites W2808013179 @default.
- W4386424279 cites W2940073658 @default.
- W4386424279 cites W2953378144 @default.
- W4386424279 cites W2999721497 @default.
- W4386424279 cites W3003349663 @default.
- W4386424279 cites W3009471311 @default.
- W4386424279 cites W3023209255 @default.
- W4386424279 cites W3055343540 @default.
- W4386424279 cites W3118591597 @default.
- W4386424279 cites W3143776985 @default.
- W4386424279 cites W3193523732 @default.
- W4386424279 cites W3198101455 @default.
- W4386424279 cites W4225276735 @default.
- W4386424279 cites W952647933 @default.
- W4386424279 doi "https://doi.org/10.1016/j.drugalcdep.2023.110953" @default.
- W4386424279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37734282" @default.
- W4386424279 hasPublicationYear "2023" @default.
- W4386424279 type Work @default.
- W4386424279 citedByCount "0" @default.
- W4386424279 crossrefType "journal-article" @default.
- W4386424279 hasAuthorship W4386424279A5007574521 @default.
- W4386424279 hasAuthorship W4386424279A5019064242 @default.
- W4386424279 hasAuthorship W4386424279A5034893026 @default.
- W4386424279 hasAuthorship W4386424279A5035496277 @default.
- W4386424279 hasAuthorship W4386424279A5043494441 @default.
- W4386424279 hasAuthorship W4386424279A5043625052 @default.
- W4386424279 hasAuthorship W4386424279A5048006376 @default.
- W4386424279 hasAuthorship W4386424279A5056930528 @default.
- W4386424279 hasConcept C126322002 @default.
- W4386424279 hasConcept C170493617 @default.
- W4386424279 hasConcept C2776029756 @default.
- W4386424279 hasConcept C2776814716 @default.
- W4386424279 hasConcept C2778173252 @default.
- W4386424279 hasConcept C2778555786 @default.
- W4386424279 hasConcept C2778938600 @default.
- W4386424279 hasConcept C2781063702 @default.
- W4386424279 hasConcept C42219234 @default.
- W4386424279 hasConcept C71924100 @default.
- W4386424279 hasConcept C98274493 @default.
- W4386424279 hasConceptScore W4386424279C126322002 @default.
- W4386424279 hasConceptScore W4386424279C170493617 @default.
- W4386424279 hasConceptScore W4386424279C2776029756 @default.
- W4386424279 hasConceptScore W4386424279C2776814716 @default.
- W4386424279 hasConceptScore W4386424279C2778173252 @default.
- W4386424279 hasConceptScore W4386424279C2778555786 @default.
- W4386424279 hasConceptScore W4386424279C2778938600 @default.
- W4386424279 hasConceptScore W4386424279C2781063702 @default.
- W4386424279 hasConceptScore W4386424279C42219234 @default.
- W4386424279 hasConceptScore W4386424279C71924100 @default.
- W4386424279 hasConceptScore W4386424279C98274493 @default.
- W4386424279 hasFunder F4320337330 @default.
- W4386424279 hasFunder F4320337347 @default.
- W4386424279 hasLocation W43864242791 @default.
- W4386424279 hasLocation W43864242792 @default.
- W4386424279 hasOpenAccess W4386424279 @default.
- W4386424279 hasPrimaryLocation W43864242791 @default.
- W4386424279 hasRelatedWork W2005929448 @default.
- W4386424279 hasRelatedWork W2362169642 @default.
- W4386424279 hasRelatedWork W2411727155 @default.
- W4386424279 hasRelatedWork W2890117474 @default.
- W4386424279 hasRelatedWork W2996124111 @default.
- W4386424279 hasRelatedWork W3185240436 @default.
- W4386424279 hasRelatedWork W4211180768 @default.
- W4386424279 hasRelatedWork W4280510130 @default.
- W4386424279 hasRelatedWork W4280619665 @default.